U.S. Code » Title 42 » Chapter CHAPTER 6A— PUBLIC HEALTH SERVICE › Subchapter SUBCHAPTER III— NATIONAL RESEARCH INSTITUTES › Part Part H— General Provisions

42 U.S.C. § 289b

Office of Research Integrity

Read at: OLRCuscode.house.gov CornellLII GovInfogovinfo.gov JustiaTitle 42 CasesGoogle Scholar
(a) In general(1) Establishment of Office

Not later than 90 days after June 10, 1993, the Secretary shall establish an office to be known as the Office of Research Integrity (referred to in this section as the “Office”), which shall be established as an independent entity in the Department of Health and Human Services.

(2) Appointment of Director

The Office shall be headed by a Director, who shall be appointed by the Secretary, be experienced and specially trained in the conduct of research, and have experience in the conduct of investigations of research misconduct. The Secretary shall carry out this section acting through the Director of the Office. The Director shall report to the Secretary.

(3) Definitions(A) The Secretary shall by regulation establish a definition for the term “research misconduct” for purposes of this section.(B) For purposes of this section, the term “financial assistance” means a grant, contract, or cooperative agreement.(b) Existence of administrative processes as condition of funding for researchThe Secretary shall by regulation require that each entity that applies for financial assistance under this chapter for any project or program that involves the conduct of biomedical or behavioral research submit in or with its application for such assistance—(1) assurances satisfactory to the Secretary that such entity has established and has in effect (in accordance with regulations which the Secretary shall prescribe) an administrative process to review reports of research misconduct in connection with biomedical and behavioral research conducted at or sponsored by such entity;(2) an agreement that the entity will report to the Director any investigation of alleged research misconduct in connection with projects for which funds have been made available under this chapter that appears substantial; and(3) an agreement that the entity will comply with regulations issued under this section.(c) Process for response of DirectorThe Secretary shall by regulation establish a process to be followed by the Director for the prompt and appropriate—(1) response to information provided to the Director respecting research misconduct in connection with projects for which funds have been made available under this chapter;(2) receipt of reports by the Director of such information from recipients of funds under this chapter;(3) conduct of investigations, when appropriate; and(4) taking of other actions, including appropriate remedies, with respect to such misconduct.(d) Monitoring by Director

The Secretary shall by regulation establish procedures for the Director to monitor administrative processes and investigations that have been established or carried out under this section.

(e) Protection of whistleblowers(1) In generalIn the case of any entity required to establish administrative processes under subsection (b), the Secretary shall by regulation establish standards for preventing, and for responding to the occurrence of retaliation by such entity, its officials or agents, against an employee in the terms and conditions of employment in response to the employee having in good faith—(A) made an allegation that the entity, its officials or agents, has engaged in or failed to adequately respond to an allegation of research misconduct; or(B) cooperated with an investigation of such an allegation.(2) Monitoring by Secretary

The Secretary shall by regulation establish procedures for the Director to monitor the implementation of the standards established by an entity under paragraph (1) for the purpose of determining whether the procedures have been established, and are being utilized, in accordance with the standards established under such paragraph.

(3) Noncompliance

The Secretary shall by regulation establish remedies for noncompliance by an entity, its officials or agents, which has engaged in retaliation in violation of the standards established under paragraph (1). Such remedies may include termination of funding provided by the Secretary for such project or recovery of funding being provided by the Secretary for such project, or other actions as appropriate.

(July 1, 1944, ch. 373, title IV, § 493, as added Pub. L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 874; amended Pub. L. 103–43, title I, §§ 161, 163, June 10, 1993, 107 Stat. 140, 142.)Editorial NotesCodification

June 10, 1993, referred to in subsec. (a)(1), was in the original “the date of enactment of this section” which was translated as meaning the date of enactment of Pub. L. 103–43, which amended this section generally, to reflect the probable intent of Congress.

Amendments

1993—Pub. L. 103–43, § 161, amended section generally. Prior to amendment, section read as follows:

“(a) The Secretary shall by regulation require that each entity which applies for a grant, contract, or cooperative agreement under this chapter for any project or program which involves the conduct of biomedical or behavioral research submit in or with its application for such grant, contract, or cooperative agreement assurances satisfactory to the Secretary that such entity—

“(1) has established (in accordance with regulations which the Secretary shall prescribe) an administrative process to review reports of scientific fraud in connection with biomedical and behavioral research conducted at or sponsored by such entity; and

“(2) will report to the Secretary any investigation of alleged scientific fraud which appears substantial.

“(b) The Director of NIH shall establish a process for the prompt and appropriate response to information provided the Director of NIH respecting scientific fraud in connection with projects for which funds have been made available under this chapter. The process shall include procedures for the receiving of reports of such information from recipients of funds under this chapter and taking appropriate action with respect to such fraud.”

Subsec. (e). Pub. L. 103–43, § 163, added subsec. (e).

Statutory Notes and Related SubsidiariesRegulations

Pub. L. 103–43, title I, § 165, June 10, 1993, 107 Stat. 143, provided that:“(a)Issuance of Final Rules.—“(1)In general.—Not later than 180 days after the date of the enactment of this Act [June 10, 1993], the Secretary shall, subject to paragraph (2), issue the final rule for each regulation required in section 493 or 493A of the Public Health Service Act [42 U.S.C. 289b, 289b–1].“(2)Definition of research misconduct.—Not later than 90 days after the date on which the report required in section 162(e) [107 Stat. 142] is submitted to the Secretary, the Secretary shall issue the final rule for the regulations required in section 493 of the Public Health Service Act with respect to the definition of the term ‘research misconduct’.“(b)Applicability to Ongoing Investigations.—The final rule issued pursuant to subsection (a) for investigations under section 493 of the Public Health Service Act [42 U.S.C. 289b] does not apply to investigations commenced before the date of the enactment of this Act [June 10, 1993] under authority of such section as in effect before such date.“(c)Definitions.—For purposes of this section:“(1) The term ‘section 493 of the Public Health Service Act’ means such section [42 U.S.C. 289b] as amended by sections 161 and 163 of this Act, except as indicated otherwise in subsection (b).“(2) The term ‘section 493A of the Public Health Service Act’ means such section [42 U.S.C. 289b–1] as added by section 164 of this Act.“(3) The term ‘Secretary’ means the Secretary of Health and Human Services.”

Notes of Decisions
Cited in 15 cases (3 in the last 5 years), 1990–2023 · leading case: Yuan v. Johns Hopkins Univ., 157 A.3d 254 (Md. 2017).
Sort: Relevance Newest Treatment
Yuan v. Johns Hopkins Univ., 157 A.3d 254 (Md. 2017). · cites it 5× “Yuan’s allegation that he was wrongfully terminated in retaliation for his repeated protests *440 of research misconduct in violation of 42 U.S.C. § 289b and 42 C.F.R. Part 93. 1 We hold that these provisions regarding research misconduct do not provide a clear public policy to…”
Kumar, ph.D. v. George Washington Univ., 174 F. Supp. 3d 172 (D.D.C. 2016). · cites it 5× “The Act then created a separate section, codified as amended at 42 U.S.C. § 289b, for the protection against scientific fraud.”
Yuan v. Johns Hopkins Univ., 135 A.3d 519 (Md. Ct. Spec. App. 2016). · cites it 7× “The premise of Yuan’s claim is that he was discharged for reporting “research misconduct” — reporting protected from retaliation by 42 U.S.C. § 289b and 42 C.F.R. Part 93. For reasons more fully set forth below, we conclude that the broad language and complex nature of these…”
Mauvis-Jarvis v. Wong, 2013 IL App (1st) 120070 (Ill. App. Ct. 2013). · cites it 2× “The Federal Regulations ¶5 Pursuant to the Public Health and Welfare Act (42 U.S.C. § 289b (2008)) the Secretary of the United States Department of Health and Human Services (HHS) has established an agency, the Office of Research Integrity (ORI), within the Public Health Service…”
Anversa v. Partners Healthcare Sys., Inc., 835 F.3d 167 (1st Cir. 2016). “To this end, Congress created the Office of Research Integrity (ORI) within the Department of Health and Human Services (HHS), see 42 U.S.C. § 289b(a)(l), and tasked ORI with responsibility for carrying out regulations to be promulgated by the Secretary of HHS (the Secretary)…”
Medici v. Lifespan Corp., 239 F. Supp. 3d 355 (D. Mass. 2017). “42 U.S.C. § 289b. As directed by statute, HHS has developed a detailed regulatory scheme for reviewing allegations of research misconduct.”
Dr. Charles W. McCutchen Appellee/cross-Appellant v. U.S. Dep't of Health & Human Servs., Appellant/cross-Appellee, 30 F.3d 183 (D.C. Cir. 1994). “Congress, however, specifically provided for investigations by entities receiving research grants, 42 U.S.C. § 289b(a)(l), and required them to “report to the Secretary [of HHS] any investigation of alleged scientific fraud which appears substantial.”
United States Ex Rel. Milam v. Regents of the Univ. of California, 912 F. Supp. 868 (D. Maryland 1995). “The Office of Research Integrity is an "independent entity in the Department of Health and Human Services,” 42 U.S.C. § 289b. ORI replaced the Office of Scientific Integrity ("OSI”) "which oversees the implementation of all PHS policies and procedures related to scientific…”
Anversa v. Partners Healthcare Sys., Inc., 116 F. Supp. 3d 22 (D. Mass. 2015). · cites it 3× “See 42 U.S.C. § 289b. 2 .The regulations require institutions to establish proceedings to investigate good-faith allegations of research misconduct and then report the results to the ORI, which in turn reviews the case and makes an independent determination as to whether…”
Abbs v. Sullivan, 756 F. Supp. 1172 (W.D. Wis. 1990). · cites it 2× “Adoption of Procedures The procedures and policies utilized in the investigation of Abbs’s alleged scientific misconduct were adopted by the Public Health Service as interim procedures in 1986 pursuant to 42 U.S.C. § 289b. These procedures were first described in a July 18,1986…”
Abbs v. Sullivan, 963 F.2d 918 (7th Cir. 1992). “Section 493(b) of the Public Health Service Act, 42 U.S.C. § 289b(b), directs NIH to establish a “process” for responding to complaints of scientific fraud.”
Shovlin v. Univ. of Med. & Dentistry of New Jersey, 50 F. Supp. 2d 297 (D.N.J. 1998). “In or about January 1991, UMDNJ adopted a "Policy on Scientific Misconduct” to implement 42 U.S.C. § 289b. The policy sets forth a procedure for investigating scientific misconduct.”
Show all 15 citing cases →
— 42 U.S.C. § 289b(a) — 1 case
Croce v. Ohio State Univ. Bd. of Trs., 2023 Ohio 2656 (Ohio Ct. Cl. 2023).
— 42 U.S.C. § 289b(a)(l) — 2 cases
Anversa v. Partners Healthcare Sys., Inc., 835 F.3d 167 (1st Cir. 2016). “To this end, Congress created the Office of Research Integrity (ORI) within the Department of Health and Human Services (HHS), see 42 U.S.C. § 289b(a)(l), and tasked ORI with responsibility for carrying out regulations to be promulgated by the Secretary of HHS (the Secretary)…”
Dr. Charles W. McCutchen Appellee/cross-Appellant v. U.S. Dep't of Health & Human Servs., Appellant/cross-Appellee, 30 F.3d 183 (D.C. Cir. 1994). “Congress, however, specifically provided for investigations by entities receiving research grants, 42 U.S.C. § 289b(a)(l), and required them to “report to the Secretary [of HHS] any investigation of alleged scientific fraud which appears substantial.”
— 42 U.S.C. § 289b(b) — 2 cases
Abbs v. Sullivan, 963 F.2d 918 (7th Cir. 1992). “Section 493(b) of the Public Health Service Act, 42 U.S.C. § 289b(b), directs NIH to establish a “process” for responding to complaints of scientific fraud.”
William Helm, mb.bchir v. Allison Ratterman, Phd (Ky. Ct. App. 2022).
— 42 U.S.C. § 289b(b)(2) — 1 case
Kumar, ph.D. v. George Washington Univ., 174 F. Supp. 3d 172 (D.D.C. 2016). “The Act then created a separate section, codified as amended at 42 U.S.C. § 289b, for the protection against scientific fraud.”
— 42 U.S.C. § 289b(b)(l) — 1 case
Kumar, ph.D. v. George Washington Univ., 174 F. Supp. 3d 172 (D.D.C. 2016). “The Act then created a separate section, codified as amended at 42 U.S.C. § 289b, for the protection against scientific fraud.”
— 42 U.S.C. § 289b(c) — 2 cases
Kumar, ph.D. v. George Washington Univ., 174 F. Supp. 3d 172 (D.D.C. 2016). “The Act then created a separate section, codified as amended at 42 U.S.C. § 289b, for the protection against scientific fraud.”
Anversa v. Partners Healthcare Sys., Inc., 116 F. Supp. 3d 22 (D. Mass. 2015). “See 42 U.S.C. § 289b. 2 .The regulations require institutions to establish proceedings to investigate good-faith allegations of research misconduct and then report the results to the ORI, which in turn reviews the case and makes an independent determination as to whether…”
— 42 U.S.C. § 289b(c)(3) — 1 case
Kumar, ph.D. v. George Washington Univ., 174 F. Supp. 3d 172 (D.D.C. 2016). “The Act then created a separate section, codified as amended at 42 U.S.C. § 289b, for the protection against scientific fraud.”
— 42 U.S.C. § 289b(e) — 1 case
Houser v. Feldman (E.D. Pa. 2021).
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.